You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

ORETIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oretic, and when can generic versions of Oretic launch?

Oretic is a drug marketed by Abbvie and is included in two NDAs.

The generic ingredient in ORETIC is deserpidine; hydrochlorothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; hydrochlorothiazide profile page.

Summary for ORETIC
Drug patent expirations by year for ORETIC
Recent Clinical Trials for ORETIC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Scripps Translational Science InstituteN/A
NovartisPhase 3

See all ORETIC clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ORETIC

US Patents and Regulatory Information for ORETIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie ORETIC hydrochlorothiazide TABLET;ORAL 011971-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie ORETICYL 50 deserpidine; hydrochlorothiazide TABLET;ORAL 012148-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie ORETIC hydrochlorothiazide TABLET;ORAL 011971-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie ORETICYL 25 deserpidine; hydrochlorothiazide TABLET;ORAL 012148-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie ORETICYL FORTE deserpidine; hydrochlorothiazide TABLET;ORAL 012148-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.